Semaphorin 7A initiates T-cell-mediated inflammatory responses through α1β1 integrin

Semaphorins are axon guidance factors that assist growing axons in finding appropriate targets and forming synapses(1). Emerging evidence suggests that semaphorins are involved not only in embryonic development but also in immune responses(2). Semaphorin 7A (Sema7A; also known as CD108)(3,4), which is a glycosylphosphatidylinositol-anchored semaphorin, promotes axon outgrowth through beta 1-integrin receptors and contributes to the formation of the lateral olfactory tract(5). Although Sema7A has been shown to stimulate human monocytes(6), its function as a negative regulator of T-cell responses has also been reported(7). Thus, the precise function of Sema7A in the immune system remains unclear. Here we show that Sema7A, which is expressed on activated T cells, stimulates cytokine production in monocytes and macrophages through alpha 1 beta 1 integrin ( also known as very late antigen-1) as a component of the immunological synapse, and is critical for the effector phase of the inflammatory immune response. Sema7A-deficient (Sema7a(-/-)) mice are defective in cell-mediated immune responses such as contact hypersensitivity and experimental autoimmune encephalomyelitis. Although antigen-specific and cytokine-producing effector T cells can develop and migrate into antigen-challenged sites in Sema7a(-/-) mice, Sema7a(-/-) T cells fail to induce contact hypersensitivity even when directly injected into the antigen-challenged sites. Thus, the interaction between Sema7A and alpha 1 beta 1 integrin is crucial at the site of inflammation. These findings not only identify a function of Sema7A as an effector molecule in T-cell-mediated inflammation, but also reveal a mechanism of integrin-mediated immune regulation.